位置:首页 > 蛋白库 > MOD5_YEAST
MOD5_YEAST
ID   MOD5_YEAST              Reviewed;         428 AA.
AC   P07884; D6W2X4; Q12203;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   03-AUG-2022, entry version 196.
DE   RecName: Full=tRNA dimethylallyltransferase;
DE            Short=DMATase;
DE            EC=2.5.1.75 {ECO:0000269|PubMed:18852462, ECO:0000269|PubMed:3031456};
DE   AltName: Full=Isopentenyl-diphosphate: tRNA isopentenyltransferase;
DE            Short=IPP transferase;
DE            Short=IPPT;
DE   AltName: Full=tRNA isopentenyltransferase;
DE            Short=IPTase;
GN   Name=MOD5; OrderedLocusNames=YOR274W;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3031457; DOI=10.1128/mcb.7.1.185-191.1987;
RA   Najarian D., Dihanich M.E., Martin N.C., Hopper A.K.;
RT   "DNA sequence and transcript mapping of MOD5: features of the 5' region
RT   which suggest two translational starts.";
RL   Mol. Cell. Biol. 7:185-191(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=8896271;
RX   DOI=10.1002/(sici)1097-0061(199609)12:10b%3c1059::aid-yea994%3e3.0.co;2-7;
RA   Cheret G., Bernardi A., Sor F.J.;
RT   "DNA sequence analysis of the VPH1-SNF2 region on chromosome XV of
RT   Saccharomyces cerevisiae.";
RL   Yeast 12:1059-1064(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169874;
RA   Dujon B., Albermann K., Aldea M., Alexandraki D., Ansorge W., Arino J.,
RA   Benes V., Bohn C., Bolotin-Fukuhara M., Bordonne R., Boyer J., Camasses A.,
RA   Casamayor A., Casas C., Cheret G., Cziepluch C., Daignan-Fornier B.,
RA   Dang V.-D., de Haan M., Delius H., Durand P., Fairhead C., Feldmann H.,
RA   Gaillon L., Galisson F., Gamo F.-J., Gancedo C., Goffeau A., Goulding S.E.,
RA   Grivell L.A., Habbig B., Hand N.J., Hani J., Hattenhorst U., Hebling U.,
RA   Hernando Y., Herrero E., Heumann K., Hiesel R., Hilger F., Hofmann B.,
RA   Hollenberg C.P., Hughes B., Jauniaux J.-C., Kalogeropoulos A.,
RA   Katsoulou C., Kordes E., Lafuente M.J., Landt O., Louis E.J., Maarse A.C.,
RA   Madania A., Mannhaupt G., Marck C., Martin R.P., Mewes H.-W., Michaux G.,
RA   Paces V., Parle-McDermott A.G., Pearson B.M., Perrin A., Pettersson B.,
RA   Poch O., Pohl T.M., Poirey R., Portetelle D., Pujol A., Purnelle B.,
RA   Ramezani Rad M., Rechmann S., Schwager C., Schweizer M., Sor F., Sterky F.,
RA   Tarassov I.A., Teodoru C., Tettelin H., Thierry A., Tobiasch E.,
RA   Tzermia M., Uhlen M., Unseld M., Valens M., Vandenbol M., Vetter I.,
RA   Vlcek C., Voet M., Volckaert G., Voss H., Wambutt R., Wedler H.,
RA   Wiemann S., Winsor B., Wolfe K.H., Zollner A., Zumstein E., Kleine K.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XV.";
RL   Nature 387:98-102(1997).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=3031456; DOI=10.1128/mcb.7.1.177-184.1987;
RA   Dihanich M.E., Najarian D., Clark R., Gillman E.C., Martin N.C.,
RA   Hopper A.K.;
RT   "Isolation and characterization of MOD5, a gene required for
RT   isopentenylation of cytoplasmic and mitochondrial tRNAs of Saccharomyces
RT   cerevisiae.";
RL   Mol. Cell. Biol. 7:177-184(1987).
RN   [6]
RP   ALTERNATIVE INITIATION, AND SUBCELLULAR LOCATION.
RX   PubMed=1946403; DOI=10.1073/pnas.88.21.9789;
RA   Slusher L.B., Gillman E.C., Martin N.C., Hopper A.K.;
RT   "mRNA leader length and initiation codon context determine alternative AUG
RT   selection for the yeast gene MOD5.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:9789-9793(1991).
RN   [7]
RP   ALTERNATIVE INITIATION, AND SUBCELLULAR LOCATION.
RX   PubMed=1850093; DOI=10.1128/mcb.11.5.2382-2390.1991;
RA   Gillman E.C., Slusher L.B., Martin N.C., Hopper A.K.;
RT   "MOD5 translation initiation sites determine N6-isopentenyladenosine
RT   modification of mitochondrial and cytoplasmic tRNA.";
RL   Mol. Cell. Biol. 11:2382-2390(1991).
RN   [8]
RP   ALTERNATIVE INITIATION, AND SUBCELLULAR LOCATION.
RX   PubMed=8139535; DOI=10.1128/mcb.14.4.2298-2306.1994;
RA   Boguta M., Hunter L.A., Shen W.C., Gillman E.C., Martin N.C., Hopper A.K.;
RT   "Subcellular locations of MOD5 proteins: mapping of sequences sufficient
RT   for targeting to mitochondria and demonstration that mitochondrial and
RT   nuclear isoforms commingle in the cytosol.";
RL   Mol. Cell. Biol. 14:2298-2306(1994).
RN   [9]
RP   FUNCTION.
RX   PubMed=10618371; DOI=10.1073/pnas.97.1.61;
RA   Benko A.L., Vaduva G., Martin N.C., Hopper A.K.;
RT   "Competition between a sterol biosynthetic enzyme and tRNA modification in
RT   addition to changes in the protein synthesis machinery causes altered
RT   nonsense suppression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:61-66(2000).
RN   [10]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [11]
RP   FUNCTION.
RX   PubMed=21873461; DOI=10.1261/rna.2628611;
RA   Lamichhane T.N., Blewett N.H., Maraia R.J.;
RT   "Plasticity and diversity of tRNA anticodon determinants of substrate
RT   recognition by eukaryotic A37 isopentenyltransferases.";
RL   RNA 17:1846-1857(2011).
RN   [12]
RP   PRION FORMATION, SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=22517861; DOI=10.1126/science.1219491;
RA   Suzuki G., Shimazu N., Tanaka M.;
RT   "A yeast prion, Mod5, promotes acquired drug resistance and cell survival
RT   under environmental stress.";
RL   Science 336:355-359(2012).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.95 ANGSTROMS) OF 13-421 IN COMPLEXES WITH
RP   SUBSTRATE TRNA; ISOPENTENYL DIPHOSPHATE AND ZINC IONS, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=18852462; DOI=10.1073/pnas.0805680105;
RA   Zhou C., Huang R.H.;
RT   "Crystallographic snapshots of eukaryotic dimethylallyltransferase acting
RT   on tRNA: insight into tRNA recognition and reaction mechanism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:16142-16147(2008).
CC   -!- FUNCTION: Catalyzes the transfer of a dimethylallyl group onto the
CC       adenine at position 37 in the anticodon loop on a specific subset of
CC       tRNAs both in the cytosol and the mitochondrion, leading to the
CC       formation of N6-(dimethylallyl)adenosine (i(6)A). This modification
CC       optimizes the codon:anticodon fit in the ribosome and promotes
CC       translational fidelity. Competes with the farnesyl pyrophosphate
CC       synthase ERG20 for the common substrate dimethylallyl diphosphate
CC       (DMAPP). {ECO:0000269|PubMed:10618371, ECO:0000269|PubMed:21873461,
CC       ECO:0000269|PubMed:3031456}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenosine(37) in tRNA + dimethylallyl diphosphate =
CC         diphosphate + N(6)-dimethylallyladenosine(37) in tRNA;
CC         Xref=Rhea:RHEA:26482, Rhea:RHEA-COMP:10162, Rhea:RHEA-COMP:10375,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57623, ChEBI:CHEBI:74411,
CC         ChEBI:CHEBI:74415; EC=2.5.1.75;
CC         Evidence={ECO:0000269|PubMed:18852462, ECO:0000269|PubMed:3031456};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:26483;
CC         Evidence={ECO:0000269|PubMed:18852462, ECO:0000269|PubMed:3031456};
CC   -!- SUBCELLULAR LOCATION: Note=[MOD+] forms multicytoplasmic aggregates
CC       that do not colocalize to either mitochondria or nucleus.
CC       {ECO:0000269|PubMed:22517861}.
CC   -!- SUBCELLULAR LOCATION: [Isoform I]: Cytoplasm
CC       {ECO:0000269|PubMed:1850093, ECO:0000269|PubMed:8139535}. Mitochondrion
CC       {ECO:0000269|PubMed:1850093, ECO:0000269|PubMed:1946403,
CC       ECO:0000269|PubMed:8139535}.
CC   -!- SUBCELLULAR LOCATION: [Isoform II]: Cytoplasm
CC       {ECO:0000269|PubMed:1850093, ECO:0000269|PubMed:1946403,
CC       ECO:0000269|PubMed:8139535}. Nucleus {ECO:0000269|PubMed:8139535}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=I; Synonyms=IPPT-I {ECO:0000303|PubMed:8139535};
CC         IsoId=P07884-1; Sequence=Displayed;
CC       Name=II; Synonyms=IPPT-II {ECO:0000303|PubMed:8139535};
CC         IsoId=P07884-2; Sequence=VSP_018811;
CC   -!- DOMAIN: The core aggregation region, although lacking the prion-typical
CC       Gln/Asn (Q/N)-rich domain, is required for the formation of the
CC       amyloid-like fibrillar aggregates. {ECO:0000305|PubMed:22517861}.
CC   -!- MISCELLANEOUS: [MOD+] is the prion form of MOD5. [MOD+] is the result
CC       of a conformational change of the cellular MOD5 protein that becomes
CC       self-propagating and infectious. This conformational change generates a
CC       form of MOD5 that assembles into amyloid-like fibrillar aggregates.
CC       [MOD+]-aggregates sequester soluble MOD5, resulting in decreased levels
CC       of (i(6)A)-modified tRNAs and higher ergosterol levels, due to less
CC       competition for ERG20, which uses the same substrate DMAPP than MOD5.
CC       [MOD+] can be cured by GdnHCl and by deletion of the molecular
CC       chaperone HSP104, which is required for [MOD+] propagation. The [MOD+]
CC       state acquires resistance against antifungal agents such as
CC       flucanozole, ketoconazole and clotrimazole that inhibit ergosterol
CC       biosynthesis. De novo appearance of [MOD+] is favored in the presence
CC       of antifungal agents, and the growth advantage of [MOD+] is lost when
CC       the cells are released from the selective pressure. Thus, the
CC       conformational switch of MOD5 from a soluble state to a prion state
CC       allows the cell to adapt to the harmful environment of anti-fungal
CC       drugs by up-regulating ergosterol biosynthesis at the expense of tRNA
CC       modification. {ECO:0000305|PubMed:22517861}.
CC   -!- MISCELLANEOUS: Present with 2020 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the IPP transferase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M15991; AAA34785.1; -; Genomic_DNA.
DR   EMBL; X89633; CAA61780.1; -; Genomic_DNA.
DR   EMBL; Z75182; CAA99499.1; -; Genomic_DNA.
DR   EMBL; BK006948; DAA11040.1; -; Genomic_DNA.
DR   PIR; S67176; S67176.
DR   RefSeq; NP_014917.3; NM_001183693.3. [P07884-1]
DR   PDB; 3EPH; X-ray; 2.95 A; A/B=13-421.
DR   PDB; 3EPJ; X-ray; 3.10 A; A/B=13-421.
DR   PDB; 3EPK; X-ray; 3.20 A; A/B=13-421.
DR   PDB; 3EPL; X-ray; 3.60 A; A/B=13-421.
DR   PDBsum; 3EPH; -.
DR   PDBsum; 3EPJ; -.
DR   PDBsum; 3EPK; -.
DR   PDBsum; 3EPL; -.
DR   AlphaFoldDB; P07884; -.
DR   SMR; P07884; -.
DR   BioGRID; 34663; 106.
DR   DIP; DIP-4094N; -.
DR   IntAct; P07884; 2.
DR   STRING; 4932.YOR274W; -.
DR   MaxQB; P07884; -.
DR   PaxDb; P07884; -.
DR   PRIDE; P07884; -.
DR   EnsemblFungi; YOR274W_mRNA; YOR274W; YOR274W. [P07884-1]
DR   GeneID; 854448; -.
DR   KEGG; sce:YOR274W; -.
DR   SGD; S000005800; MOD5.
DR   VEuPathDB; FungiDB:YOR274W; -.
DR   eggNOG; KOG1384; Eukaryota.
DR   GeneTree; ENSGT00390000015214; -.
DR   HOGENOM; CLU_032616_2_3_1; -.
DR   InParanoid; P07884; -.
DR   OMA; YAKRQYT; -.
DR   BioCyc; YEAST:YOR274W-MON; -.
DR   BRENDA; 2.5.1.75; 984.
DR   EvolutionaryTrace; P07884; -.
DR   PRO; PR:P07884; -.
DR   Proteomes; UP000002311; Chromosome XV.
DR   RNAct; P07884; protein.
DR   GO; GO:0005829; C:cytosol; IDA:SGD.
DR   GO; GO:0005739; C:mitochondrion; IDA:SGD.
DR   GO; GO:0005730; C:nucleolus; IDA:SGD.
DR   GO; GO:0005634; C:nucleus; IDA:SGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000049; F:tRNA binding; IDA:SGD.
DR   GO; GO:0052381; F:tRNA dimethylallyltransferase activity; IDA:SGD.
DR   GO; GO:0061587; P:transfer RNA gene-mediated silencing; IMP:SGD.
DR   GO; GO:0006400; P:tRNA modification; IDA:SGD.
DR   Gene3D; 3.40.50.300; -; 1.
DR   HAMAP; MF_00185; IPP_trans; 1.
DR   InterPro; IPR039657; Dimethylallyltransferase.
DR   InterPro; IPR030666; IPP_transferase_euk.
DR   InterPro; IPR018022; IPT.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11088; PTHR11088; 1.
DR   PIRSF; PIRSF039110; IPP_transferase; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00174; miaA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Amyloid; ATP-binding; Cytoplasm;
KW   Metal-binding; Mitochondrion; Nucleotide-binding; Nucleus; Prion;
KW   Reference proteome; Transferase; tRNA processing; Zinc; Zinc-finger.
FT   CHAIN           1..428
FT                   /note="tRNA dimethylallyltransferase"
FT                   /id="PRO_0000019025"
FT   ZN_FING         373..409
FT                   /note="Matrin-type"
FT   REGION          46..49
FT                   /note="Interaction with substrate tRNA"
FT                   /evidence="ECO:0000269|PubMed:18852462"
FT   REGION          170..174
FT                   /note="Interaction with substrate tRNA"
FT                   /evidence="ECO:0000269|PubMed:18852462"
FT   REGION          199..207
FT                   /note="Core aggregation region"
FT                   /evidence="ECO:0000269|PubMed:18852462"
FT   REGION          210..232
FT                   /note="Interaction with isopentenylpyrophosphate
FT                   transferase"
FT                   /evidence="ECO:0000269|PubMed:18852462"
FT   REGION          256..258
FT                   /note="Interaction with substrate tRNA"
FT                   /evidence="ECO:0000269|PubMed:18852462"
FT   REGION          284..302
FT                   /note="Interaction with substrate tRNA"
FT                   /evidence="ECO:0000269|PubMed:18852462"
FT   BINDING         21..28
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   BINDING         23..28
FT                   /ligand="dimethylallyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:57623"
FT                   /evidence="ECO:0000269|PubMed:18852462"
FT   BINDING         375
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:18852462,
FT                   ECO:0007744|PDB:3EPH, ECO:0007744|PDB:3EPJ,
FT                   ECO:0007744|PDB:3EPK, ECO:0007744|PDB:3EPL"
FT   BINDING         378
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:18852462,
FT                   ECO:0007744|PDB:3EPH, ECO:0007744|PDB:3EPJ,
FT                   ECO:0007744|PDB:3EPK, ECO:0007744|PDB:3EPL"
FT   BINDING         397
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:18852462,
FT                   ECO:0007744|PDB:3EPH, ECO:0007744|PDB:3EPJ,
FT                   ECO:0007744|PDB:3EPK, ECO:0007744|PDB:3EPL"
FT   BINDING         403
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:18852462,
FT                   ECO:0007744|PDB:3EPH, ECO:0007744|PDB:3EPJ,
FT                   ECO:0007744|PDB:3EPK, ECO:0007744|PDB:3EPL"
FT   SITE            112
FT                   /note="Interaction with substrate tRNA"
FT                   /evidence="ECO:0000269|PubMed:18852462"
FT   SITE            193
FT                   /note="Interaction with substrate tRNA"
FT                   /evidence="ECO:0000269|PubMed:18852462"
FT   VAR_SEQ         1..11
FT                   /note="Missing (in isoform II)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_018811"
FT   CONFLICT        313
FT                   /note="Missing (in Ref. 1; AAA34785)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        375
FT                   /note="C -> R (in Ref. 1; AAA34785)"
FT                   /evidence="ECO:0000305"
FT   STRAND          15..21
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   STRAND          23..26
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           27..38
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   STRAND          40..44
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   TURN            47..50
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   STRAND          51..53
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   TURN            55..59
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           63..65
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   TURN            66..68
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   STRAND          71..73
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           85..100
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   TURN            101..103
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   STRAND          105..109
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           113..120
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   STRAND          127..129
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           135..141
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   STRAND          144..148
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           149..155
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           158..161
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           169..182
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           186..191
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   STRAND          198..207
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           210..226
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           229..240
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   TURN            241..244
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           247..249
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           253..256
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           261..267
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           278..302
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           304..307
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   TURN            308..310
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   STRAND          312..316
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   TURN            320..322
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   TURN            324..327
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           328..339
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           351..357
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           359..361
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           363..365
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   STRAND          372..379
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   STRAND          385..390
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           391..398
FT                   /evidence="ECO:0007829|PDB:3EPH"
FT   HELIX           401..418
FT                   /evidence="ECO:0007829|PDB:3EPH"
SQ   SEQUENCE   428 AA;  50237 MW;  A956B17ABC05161F CRC64;
     MLKGPLKGCL NMSKKVIVIA GTTGVGKSQL SIQLAQKFNG EVINSDSMQV YKDIPIITNK
     HPLQEREGIP HHVMNHVDWS EEYYSHRFET ECMNAIEDIH RRGKIPIVVG GTHYYLQTLF
     NKRVDTKSSE RKLTRKQLDI LESTDPDVIY NTLVKCDPDI ATKYHPNDYR RVQRMLEIYY
     KTGKKPSETF NEQKITLKFD TLFLWLYSKP EPLFQRLDDR VDDMLERGAL QEIKQLYEYY
     SQNKFTPEQC ENGVWQVIGF KEFLPWLTGK TDDNTVKLED CIERMKTRTR QYAKRQVKWI
     KKMLIPDIKG DIYLLDATDL SQWDTNASQR AIAISNDFIS NRPIKQERAP KALEELLSKG
     ETTMKKLDDW THYTCNVCRN ADGKNVVAIG EKYWKIHLGS RRHKSNLKRN TRQADFEKWK
     INKKETVE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024